Tag: TB
Qure.ai secures major global health grant to build AI-powered point-of-care ultrasound
AI innovation will improve diagnostics of preventable infectious disease including TB & pneumonia for global health progress
How India is Countering the Growing Challenge of Drug-Resistant TB
Treating TB without knowing whether the bacteria are resistant in the individual can waste months and worsen the disease, writes Dr Gunisha Pasricha, Principal Scientist & Infectious Diseases Expert, MedGenome Labs
Health Minister J P Nadda releases 10th edition of Indian pharmacopoeia
Indian Pharmacopoeia 2026 expands coverage of anti-TB, anti-diabetic and anti-cancer medicines with 121 new monographs
Biofabri, Bharat Biotech sign tech transfer deal for TB vaccine MTBVAC
MTBVAC represents a critically important advance in global TB prevention, as it’s one of two vaccine candidates that have progressed into advanced clinical development.
TB incidence in India has fallen by 21% in the last...
Treatment coverage increases to 92%, placing India ahead of other high-burden countries and global universal health coverage
Qure.ai announces world’s first AI-powered paediatric TB screening tool
AI tool regulatory cleared for early detection of TB in children aged 0-3 years, promising faster diagnosis
Vgenomics & Meril Genomics collaborate to revolutionize precision medicine in India
Access to NIPT, TB and Rare Disease diagnostics to benefit thousands of patients nationwide
Paras Health reports increment in total number of newly diagnosed pulmonary...
According to the latest data, India’s National TB Elimination Program (NTEP) recorded 26.07 lakh TB cases in 2024—the highest ever reported
World TB Day 2025 Summit: JP Nadda reiterates govt’s commitment to...
Under the 100-day TB Mukt Bharat Abhiyaan, 12.97 crore people were screened for TB with over 7.19 lakh TB patients notified across India
World Tuberculosis Day 2025: Funding cuts threaten global TB control efforts,...
The recent funding cuts to TB programs, particularly from the US, that raise serious concerns about the future of TB control and treatment efforts